1 reports of this reaction
1.0% of all DEXTROSE(GLUCOSE),LEVULOSE(FRUCTOSE),PHOSPHORIC ACID reports
#19 most reported adverse reaction
DEAFNESS is the #19 most commonly reported adverse reaction for DEXTROSE(GLUCOSE),LEVULOSE(FRUCTOSE),PHOSPHORIC ACID, manufactured by Cardinal Health. There are 1 FDA adverse event reports linking DEXTROSE(GLUCOSE),LEVULOSE(FRUCTOSE),PHOSPHORIC ACID to DEAFNESS. This represents approximately 1.0% of all 101 adverse event reports for this drug.
Patients taking DEXTROSE(GLUCOSE),LEVULOSE(FRUCTOSE),PHOSPHORIC ACID who experience deafness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEAFNESS is a less commonly reported adverse event for DEXTROSE(GLUCOSE),LEVULOSE(FRUCTOSE),PHOSPHORIC ACID, but still significant enough to appear in the safety profile.
In addition to deafness, the following adverse reactions have been reported for DEXTROSE(GLUCOSE),LEVULOSE(FRUCTOSE),PHOSPHORIC ACID:
The following drugs have also been linked to deafness in FDA adverse event reports:
DEAFNESS has been reported as an adverse event in 1 FDA reports for DEXTROSE(GLUCOSE),LEVULOSE(FRUCTOSE),PHOSPHORIC ACID. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEAFNESS accounts for approximately 1.0% of all adverse event reports for DEXTROSE(GLUCOSE),LEVULOSE(FRUCTOSE),PHOSPHORIC ACID, making it a notable side effect.
If you experience deafness while taking DEXTROSE(GLUCOSE),LEVULOSE(FRUCTOSE),PHOSPHORIC ACID, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.